Page last updated: 2024-12-06

1,3,4,6-tetrachloro-3 alpha,6 alpha-diphenylglycoluril

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1,3,4,6-tetrachloro-3α,6α-diphenylglycoluril is a **highly specific inhibitor of the enzyme glycogen synthase kinase-3β (GSK-3β)**.

Let's break down its name and its importance:

**Structure and Name:**

* **Glycoluril:** This is the core structure of the molecule, a cyclic urea derivative.
* **Tetra-chloro:** The molecule has four chlorine atoms attached to it.
* **3α,6α-diphenyl:** It has two phenyl (benzene ring) groups attached to specific positions on the glycoluril ring, designated as 3α and 6α.

**Importance in Research:**

GSK-3β is a crucial enzyme involved in a wide range of cellular processes, including:

* **Cell proliferation and differentiation:** GSK-3β plays a role in controlling cell growth and development.
* **Insulin signaling:** It is involved in the regulation of glucose metabolism and insulin sensitivity.
* **Inflammation:** GSK-3β contributes to the inflammatory response in the body.
* **Neurodegenerative diseases:** Aberrant GSK-3β activity is linked to neurodegenerative disorders like Alzheimer's disease.

**Therefore, 1,3,4,6-tetrachloro-3α,6α-diphenylglycoluril is a valuable tool for researchers:**

* **Studying GSK-3β function:** By specifically inhibiting the enzyme, researchers can investigate its role in different cellular processes and diseases.
* **Drug development:** It is a potential lead compound for the development of drugs targeting GSK-3β, which could be useful for treating a variety of conditions, such as diabetes, inflammation, and neurodegeneration.

**Key Points:**

* This compound is a highly potent and selective inhibitor of GSK-3β.
* Its unique chemical structure allows for precise targeting of the enzyme.
* It serves as a valuable research tool for understanding GSK-3β function and developing new therapies.

1,3,4,6-tetrachloro-3 alpha,6 alpha-diphenylglycoluril: reagent for protein iodinations; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID40065
SCHEMBL ID763669
MeSH IDM0059359

Synonyms (30)

Synonym
nsc-4462
51592-06-4
nsc4462
imidazo[4,5(1h,3h)-dione, 1,3,4,6-tetrachlorotetrahydro-3a,6a-diphenyl-
imidazo[4,5-d]imidazole-2,5(1h,3h)-dione, 1,3,4,6-tetrachlorotetrahydro-3a,6a-diphenyl-
1,3,4,6-tetrachloro-3a,6a-diphenyl-imidazo[4,5-d]imidazole-2,5-dione
brn 0363328
iodo-gen
glycoluril, 1,3,4,6-tetrachloro-3a,6a-diphenyl-
nsc 4462
1,3,4,6-tetrachlorotetrahydro-3a, 6a-diphenylimidazo(4,5-d)imidazole-2,5(1h,3h)-dione
imidazo(4,5-d)imidazole-2,5(1h,3h)-dione, 1,3,4,6-tetrachlorotetrahydro-3a,6a-diphenyl-
1,3,4,6-tetrachloro-3a,6a-diphenylglycoluril
1,3,4,6-tetrachloro-3alpha,6alpha-diphenyl-glycoluril
1,3,4,6-tetrachloro-3alpha,6alpha-diphenylglycouril
1,3,4,6-tetrachloro-3a,6a-diphenylimidazo[4,5-d]imidazole-2,5-dione
1,3,4,6-tetrachloro-3 alpha,6 alpha-diphenylglycoluril
iodogen
FT-0606491
DTXSID0068652
SCHEMBL763669
1,3,4,6-tetrachloro-3alpha,6alpha-diphenylglycoluril
1,3,4,6-tetrachloro-3a,6a-*diphenylglycouril
1,3,4,6-tetrachloro-3a,6a-diphenyltetrahydroimidazo[4,5-d]imidazole-2,5(1h,3h)-dione
AMY37046
1,3,4,6-tetrachloro-3-6-diphenylglycouril
1,3,4,6-tetrachloro-3alpha,6alpha-di-phenylglycouril
CS-0453184
1,3,4,6-tetrachloro-3a,6a-diphenyl-tetrahydro-imidazo[4,5-d]imidazole-2,5-dione
1,3,4,6-tetrachloro-3 alpha ,6 alpha -diphenylglycouril

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"The aim of this study was to develop a safe and simple radiolabeling and purification procedure for high-dose (131)I-rituximab for treatment of patients with non-Hodgkin's lymphoma."( A simple and safe method for 131I radiolabeling of rituximab for myeloablative high-dose radioimmunotherapy.
Baars, JW; Beijnen, JH; Hoefnagel, CA; Huitema, AD; Maessen, HJ; Tran, L, 2009
)
0.35
" LD50 values of iodogen/DMSO were 59."( A safety study on single intravenous dose of tetrachloro-diphenyl glycoluril [iodogen] dissolved in dimethyl sulphoxide (DMSO).
Alpizar, YA; Chen, F; Cona, MM; de Witte, P; Feng, Y; Li, J; Ni, Y; Oyen, R; Sun, Z; Talavera, K; Vanstapel, F; Verbruggen, A, 2013
)
0.39

Pharmacokinetics

ExcerptReferenceRelevance
"67 h and a slow elimination proceeding with the terminal elimination half-life (T(1/2)) of 84."( Pharmacokinetics, tissue distribution and excretion of porcine fibrinogen after intraperitoneal injection of a porcine-derived fibrin glue to rats.
Fan, G; He, H; Wu, Y; Xie, Y; Zhong, G, 2011
)
0.37
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (108)

TimeframeStudies, This Drug (%)All Drugs %
pre-199067 (62.04)18.7374
1990's28 (25.93)18.2507
2000's8 (7.41)29.6817
2010's5 (4.63)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 9.40

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index9.40 (24.57)
Research Supply Index4.73 (2.92)
Research Growth Index4.13 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (9.40)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (2.68%)6.00%
Case Studies1 (0.89%)4.05%
Observational0 (0.00%)0.25%
Other108 (96.43%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]